We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Some Moderate-Risk Devices Cleared Without Pivotal Studies
Some Moderate-Risk Devices Cleared Without Pivotal Studies
A study assessing the FDA’s De Novo premarket review pathway found that some devices received clearance without supporting data from pivotal clinical trials.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor